[Effects of hexamethylenebisacetamide on the differentiation of embryonal carcinoma cells].
HMBA induces differentiation in the whole population of some multipotential embryonic carcinoma cells. Morphological, biochemical and immunological changes can be observed even after short treatment. The cells lose the embryonal F9 antigen without acquiring H-2 antigens.